November 8, 2011 | Voice of America
By Vidushi Sinha
A billion people around the world suffer from neglected tropical diseases, and the global health community is working to develop new drugs, vaccines and diagnostics. But experts note that success is uneven in part because of different rules and regulations in different countries for drug development and testing.
Dr. Peter Hotez, president of Sabin Vaccine Institute, says it is much easier to test new therapies in India than in other parts of the world.
“The good news is India is what we call IDC - Innovative Developing Country," said Hotez. "Yes, you have enormous pockets of poverty; yes, you have terrible problems with elephantiasis and hookworm, kala-azar, and leprosy. But at the same time, you have a very advanced and sophisticated biotechnology machine in India.”
Read the full article here.